Kenji Akita Selected Research

Kenji Akita Research Topics

6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 09/2002
4	Neoplasms (Cancer) 09/2023 - 09/2002
1	Fatigue 06/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2022
1	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 06/2022
1	Muscle Weakness 06/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2022
1	Pneumonia (Pneumonitis) 02/2022
1	Stomach Neoplasms (Stomach Cancer) 02/2022
1	Lung Diseases (Lung Disease) 02/2022
1	Lymphatic Metastasis 01/2021
1	Infections 12/2020
1	Chylous Ascites 12/2020
1	Flatulence 04/2012
1	Colonic Neoplasms (Colon Cancer) 04/2012
1	Lung Neoplasms (Lung Cancer) 04/2012
1	Cognitive Dysfunction 01/2012
1	Dementia (Dementias) 01/2012
1	Memory Disorders (Memory Loss) 01/2012
1	Amnesia (Dissociative Amnesia) 01/2012
1	Alzheimer Disease (Alzheimer's Disease) 01/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2011
1	Febrile Neutropenia 01/2010
1	Brain Edema (Cerebral Edema) 01/2010
1	Brain Injuries (Brain Injury) 01/2010
1	Brain Ischemia (Cerebral Ischemia) 01/2010
1	Ischemia 01/2010
1	Reperfusion Injury 01/2010
1	Breast Neoplasms (Breast Cancer) 01/2005
1	Cough 01/2005
1	Fever (Fevers) 01/2005
1	Cryptogenic Organizing Pneumonia 01/2005
1	Sarcoidosis (Schaumann Disease) 03/2004
1	Tuberculosis (Tuberculoses) 03/2004
1	Granuloma 03/2003
1	Rheumatoid Arthritis 03/2003
1	Erythema Nodosum 03/2003
1	Osteoarthritis 03/2003

2	Coloring Agents (Dyes)IBA 01/2012 - 01/2010
2	Nerve Growth Factors (Neurotrophins)IBA 02/2011 - 01/2010
1	GoldIBA 09/2023
1	atezolizumabIBA 06/2022
1	NivolumabIBA 02/2022
1	Immune Checkpoint InhibitorsIBA 02/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	AutoantibodiesIBA 12/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2020
1	InterferonsIBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 04/2012
1	Amino Acids FDA Link 04/2012
1	Hyaluronic Acid (Hyaluronan)IBA 04/2012
1	Methionine (L-Methionine)FDA Link 04/2012
1	SugarsIBA 04/2012
1	SulfurIBA 04/2012
1	Amyloid beta-PeptidesIBA 01/2012
1	Cholinergic Agents (Cholinergics)IBA 01/2012
1	Peptides (Polypeptides)IBA 01/2012
1	AcetylcholinesteraseIBA 01/2012
1	Scopolamine (Hyoscine)FDA Link 01/2012
1	amrubicinIBA 01/2010
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2010
1	AnthracyclinesIBA 01/2010
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 03/2004
1	Antirheumatic Agents (DMARD)IBA 03/2003
1	Muramidase (Lysozyme)IBA 03/2003
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2002